Experimental Estimation of Immunomodulating Activity of Tubosan, a New Russian Synthetic Drug

Tubosan, a new Russian immunostimulator is a derivative of sulfopyrimidine. It stimulated the humoral antiviral immunity in mice, provoked increasing the number of the antibody forming cells in the spleen of mice, immunized by sheep's erythrocytes, and increased the titers of the virus-neutrali...

Full description

Saved in:
Bibliographic Details
Main Authors: N. K. Chernikova, V. V. Mikhailov, S. V. Borisevich
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2020-05-01
Series:Антибиотики и Химиотерапия
Subjects:
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/564
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839591168747241472
author N. K. Chernikova
V. V. Mikhailov
S. V. Borisevich
author_facet N. K. Chernikova
V. V. Mikhailov
S. V. Borisevich
author_sort N. K. Chernikova
collection DOAJ
description Tubosan, a new Russian immunostimulator is a derivative of sulfopyrimidine. It stimulated the humoral antiviral immunity in mice, provoked increasing the number of the antibody forming cells in the spleen of mice, immunized by sheep's erythrocytes, and increased the titers of the virus-neutralizing antibodies after immunization by inactivated and live vaccines VEE. The Tubosan ability to lower the reactogenicity of the live VEE vaccine provided new perspectives for using such immunomodulators in medical practice.
format Article
id doaj-art-39c132ffb7d14a3f9de86d3d43e0d87c
institution Matheson Library
issn 0235-2990
language Russian
publishDate 2020-05-01
publisher LLC "Publishing House OKI"
record_format Article
series Антибиотики и Химиотерапия
spelling doaj-art-39c132ffb7d14a3f9de86d3d43e0d87c2025-08-03T13:04:47ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902020-05-01599-101316563Experimental Estimation of Immunomodulating Activity of Tubosan, a New Russian Synthetic DrugN. K. Chernikova0V. V. Mikhailov1S. V. Borisevich2Central Research Institute No. 48, Ministry of Defense of the Russian FederationSergiev Posad Biopharm Pravo-AlphaCentral Research Institute No. 48, Ministry of Defense of the Russian FederationTubosan, a new Russian immunostimulator is a derivative of sulfopyrimidine. It stimulated the humoral antiviral immunity in mice, provoked increasing the number of the antibody forming cells in the spleen of mice, immunized by sheep's erythrocytes, and increased the titers of the virus-neutralizing antibodies after immunization by inactivated and live vaccines VEE. The Tubosan ability to lower the reactogenicity of the live VEE vaccine provided new perspectives for using such immunomodulators in medical practice.https://www.antibiotics-chemotherapy.ru/jour/article/view/564immunostimulatorimmune responsereactogenicity
spellingShingle N. K. Chernikova
V. V. Mikhailov
S. V. Borisevich
Experimental Estimation of Immunomodulating Activity of Tubosan, a New Russian Synthetic Drug
Антибиотики и Химиотерапия
immunostimulator
immune response
reactogenicity
title Experimental Estimation of Immunomodulating Activity of Tubosan, a New Russian Synthetic Drug
title_full Experimental Estimation of Immunomodulating Activity of Tubosan, a New Russian Synthetic Drug
title_fullStr Experimental Estimation of Immunomodulating Activity of Tubosan, a New Russian Synthetic Drug
title_full_unstemmed Experimental Estimation of Immunomodulating Activity of Tubosan, a New Russian Synthetic Drug
title_short Experimental Estimation of Immunomodulating Activity of Tubosan, a New Russian Synthetic Drug
title_sort experimental estimation of immunomodulating activity of tubosan a new russian synthetic drug
topic immunostimulator
immune response
reactogenicity
url https://www.antibiotics-chemotherapy.ru/jour/article/view/564
work_keys_str_mv AT nkchernikova experimentalestimationofimmunomodulatingactivityoftubosananewrussiansyntheticdrug
AT vvmikhailov experimentalestimationofimmunomodulatingactivityoftubosananewrussiansyntheticdrug
AT svborisevich experimentalestimationofimmunomodulatingactivityoftubosananewrussiansyntheticdrug